MonitorDirect · GrowthWatch before adding
Mahindra Manulife Mid Cap Fund
Mahindra Manulife Mutual FundEquity Schemes - Mid Cap Fund8.7 years
The scheme seeks to generate long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in mid cap companies.
- NAV
- 37.9903
- 29 Oct 2026
- 1Y
- -1.0%
- Trailing CAGR
- Upside capture
- +94%
- Vs NIFTY MIDCAP 150 TRI
- Downside capture
- +82%
- Lower is better
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 75% of rolling 3-year windows.
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Prefer peers if · Prefer WhiteOak Capital Mid Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
8.7 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.76% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -33.1%. Ask whether you can hold through a similar fall.
Vs category
Pass
75% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Neelesh Dhamnaskar · 0.7 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 25.6% of the portfolio.
Browse category
Same-category peers are preloaded into compare when available.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 33%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y-1.0%
- 3Y+15.7%
- 5Y+15.2%
- 10Yn/a
- SI+17.4%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y-5.8%
- 3Y+4.7%
- 5Y+14.4%
- 10Yn/a
- Since inception
- +17.4%
- Calendar-day CAGR
- Excess 1Y
- -1.0%
- Category median, same plan and option
- 3Y win rate
- +75%
- Windows beating the median
- 3Y percentile
- 33
- Vs comparable share classes
- SIP 3Y XIRR
- +4.7%
- Simulated monthly SIP
- Worst rolling 3Y
- +11.6%
- 1411 daily-ending windows
- Median rolling 3Y
- +25.6%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 918 daily-ending windows
Official benchmark
Date-aligned against NIFTY MIDCAP 150 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
- 1Y excess
- +2.7%
- Fund minus TRI
- 3Y excess
- +1.5%
- Fund minus TRI
- Upside capture
- +94%
- Benchmark-up months
- Downside capture
- +82%
- Lower is better
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -33.1%
- Worst peak-to-trough
- Current
- -11.6%
- Below last peak
- Current spell
- 77 days
- Days below latest peak
- Time below peak
- +87%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 17 days
- 103 recovered episodes
- Longest recovery
- 448 days
- Trough to prior peak
7 Feb 2020 – 17 Nov 2020
Trough 23 Mar 2020 · recovered in 239 days
-33.1%
24 Sept 2024 – 21 Apr 2026
Trough 28 Feb 2025 · recovered in 417 days
-20.9%
18 Oct 2021 – 12 Sept 2022
Trough 20 Jun 2022 · recovered in 84 days
-20.8%
31 Aug 2018 – 31 Dec 2019
Trough 9 Oct 2018 · recovered in 448 days
-14.8%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
33
Vs category
44
Consistency
64
Risk-adjusted
60
Drawdown
17
Mean
44
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Monitor
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
- Long-term category-relative performance remains stronger than the most recent rolling 1-year windows, which have deteriorated across multiple periods.
Supporting reads
- The fund beat the category median in 75% of rolling 3-year windows.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 66 holdings · top 10 are 25.6%.
- Top 5
- 14.7%
- Top 10
- 25.6%
- Largest holding
- 3.4%
- Effective holdings
- 55.6
The Federal Bank Ltd
Financial
3.4%
Indusind Bank Ltd
Financial
3.2%
Aditya Birla Capital Ltd
Financial
2.8%
Coforge Ltd
Technology
2.6%
Glenmark Pharmaceuticals Ltd
Healthcare
2.6%
What changed
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
29 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
28 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
26 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
WhiteOak Capital Mid Cap Fund
WhiteOak Capital Mutual Fund
- 1Y
- +4.5%
- 3Y
- +20.6%
- Vol
- 14.8%
- Max DD
- -19.3%
- Sharpe
- 0.99
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher TER
Helios Mid Cap Fund
Helios Mutual Fund
- 1Y
- +2.2%
- 3Y
- n/a
- Vol
- 16.5%
- Max DD
- -16.7%
- Sharpe
- 0.79
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns
HSBC Midcap Fund
HSBC Mutual Fund
- 1Y
- +10.9%
- 3Y
- +22.2%
- Vol
- 17.2%
- Max DD
- -26.0%
- Sharpe
- 0.93
- 3Y win
- +100%
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Higher TER
BANDHAN MID CAP FUND
Bandhan Mutual Fund
- 1Y
- +2.8%
- 3Y
- +17.4%
- Vol
- 15.0%
- Max DD
- -22.7%
- Sharpe
- 0.75
- 3Y win
- +6%
- Lower volatility
- Shallower drawdown
- Higher trailing returns
Canara Robeco Mid Cap Fund
Canara Robeco Mutual Fund
- 1Y
- -1.3%
- 3Y
- +15.9%
- Vol
- 15.1%
- Max DD
- -21.2%
- Sharpe
- 0.73
- 3Y win
- 0%
- Lower volatility
- Shallower drawdown
- Higher trailing returns
Caveat: Higher TER